Metoprolol Tartrate Injection

What it’s used for

Metoprolol Tartrate Injection, USP is indicated in the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy. Metoprolol Tartrate Injection, USP is a betaadrenergic receptor inhibitor indicated for the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy (1).

How to take it

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Initiate treatment in a coronary care or similar unit immediately after the patient's hemodynamic condition has stabilized.

Important warnings

Worsening cardiac failure may occur. (5.

Common side effects

The following adverse reactions are described elsewhere in labeling: Worsening angina or myocardial infarction [ see Warnings and Precautions (5)] Worsening heart failure [ see Warnings and Precautions (5)] Worsening AV block [see Contraindications ( 4)] Most common adverse reactions: tiredness, dizziness, shortness of breath, bradycardia, hypotension, pruritus. (6.

Interactions

Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents.

Forms & strengths

37.5 MG Oral Tablet · 75 MG Oral Tablet · 10 MG/ML Oral Solution · 12.5 MG Oral Tablet · 100 MG Oral Tablet · 50 MG Oral Tablet · 25 MG Oral Tablet

Questions to ask your doctor or pharmacist

• Is this the right medicine for my condition, and how long should I take it?
• What side effects should I watch for, and which need urgent attention?
• Does this interact with my other medicines, supplements, or alcohol?
• What should I do if I miss a dose or take too much?